Literature DB >> 953934

Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency.

T S Ing, S D Mahurkar, G Dunea, J A Hayashi, H L Klawans, W S Markey.   

Abstract

Two patients with Parkinson's disease and renal insufficiency had excessively high concentrations of amantadine hydrochloride in the blood. The amounts of the drug removed by hemodialysis and peritoneal dialysis were small. However, since extrarenal elimination is negligible in such patients, frequently repeated dialysis may be required to remove the drug.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953934      PMCID: PMC1878764     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Letter: Accumulation of amantadine hydrochloride in renal insufficiency.

Authors:  T S Ing; A C Rahn; K F Armbruster; J H Oyama; H L Klawans
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

2.  Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study.

Authors:  A W Galbraith; J S Oxford; G C Schild; G I Watson
Journal:  Lancet       Date:  1969-11-15       Impact factor: 79.321

3.  Amantadine toxicity in a patient with renal insufficiency.

Authors:  K F Armbruster; A C Rahn; T S Ing; I S Halper; J H Oyama; H L Klawans
Journal:  Nephron       Date:  1974       Impact factor: 2.847

4.  Amantadine in Parkinson's disease. Review of more than two years' experience.

Authors:  R S Schwab; D C Poskanzer; A C England; R R Young
Journal:  JAMA       Date:  1972-11-13       Impact factor: 56.272

5.  Absorption, distribution and excretion of amantadine hydrochloride.

Authors:  W E Bleidner; J B Harmon; W E Hewes; T E Lynes; E C Hermann
Journal:  J Pharmacol Exp Ther       Date:  1965-12       Impact factor: 4.030

  5 in total
  1 in total

Review 1.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.